[Skip to content]

Enter search here...
Worcestershire Treatment Pathways

Prescribing Information, Dosing Schedule and Blood Monitoring Requirements (DRAFT)

This guidance does not override the individual responsibility of health professionals to make appropriate decision according to the circumstances of the individual patient in consultation with the patient and /or carer.  Health care professionals must be prepared to justify any deviation from this guidance.

IBD prescribing image
Image Map

Pathway Information

Treatment of Inflammatory Bowel Disease with Biologics, including Infliximab, Adalimumab, Golimumab and Vedolizumab (in patients over 15 years of age)

Page last updated: 12 February 2016